| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |